HomeHRTIS • HEL
add
Herantis Pharma Oyj
Previous close
€1.73
Day range
€1.69 - €1.74
Year range
€1.18 - €2.02
Market cap
41.20M EUR
Avg Volume
41.92K
P/E ratio
-
Dividend yield
-
Primary exchange
HEL
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.48M | 7.22% |
Net income | -1.60M | -19.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.56M | 30.67% |
Total assets | 5.11M | 40.13% |
Total liabilities | 3.36M | 109.14% |
Total equity | 1.75M | — |
Shares outstanding | 24.09M | — |
Price to book | 24.71 | — |
Return on assets | -72.26% | — |
Return on capital | -208.22% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.60M | -19.13% |
Cash from operations | -1.69M | -11.63% |
Cash from investing | -1.28M | -437.97% |
Cash from financing | 2.87M | 115,080.00% |
Net change in cash | -94.00K | 94.65% |
Free cash flow | -1.03M | -18.91% |
About
Founded
2008
Website
Employees
13
